Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Photoacoustic imaging agents for Alzheimer's disease described in KAERI patent

April 30, 2018

Completion of phase I study of tozuleristide in pediatric brain tumor surgery

April 25, 2018

FDA clears use of Bruker Maldi Biotyper CA system to identify C. auris

April 23, 2018

FDA finalizes guidance on NGS-based tests

April 13, 2018

5-HTT radiotracer [11C]DASB may predict remission after antidepressant treatment

April 11, 2018

Loxo Oncology and Illumina to develop pan-cancer companion diagnostics

April 11, 2018

Personal Genome Diagnostics, Five Prime Therapeutics to develop bemarituzumab companion diagnostic

April 4, 2018

CARB-X collaborates with Helixbind to support development of RaPID/BSI diagnostic test

March 16, 2018

Harbin Medical University presents data on PET tracer for EGFR mutation determination

March 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...